Angsuman Chakraborty31 Aug 2006 10:18 am
The University of Massachusetts system is formulating a strategy for stem cell research across all five campuses, with Amherst and Worcester set to lead the way in research and development.
“This is one of the most exciting and promising areas of modern molecular biology and scientific medicine,” said John A. Armstrong, the UMass trustee from Amherst who chairs the board’s Task Force on Science and Technology, yesterday. “The university does not want to be left out.”
At UMass Medical School in Worcester and the Amherst campus, scientists are working with adult stem cells, but not embryonic stem cells, said William Wright, a spokesman in the UMass president’s office.
At Amherst, there are several departments that would be included in the stem cell program. Armstrong referenced the Department of Veterinary and Animal Sciences’ curriculum, which includes the study of cell and molecular biology.
This year, the Institute for Cellular Engineering was established on campus, which encompasses the study of stem cell science and research.
Stem cells have the potential to develop into many different cell types in the body and serve as a repair system for the body, theoretically dividing without limit to replenish other cells, according to the National Institutes of Health.
Telfer’s lab uses mouse stem cells to study blood and immune systems with respect to bone marrow transplants, but other labs on campus use human adult stem cells.
Link
Filed under Stem Cell | Comment Below
Related?
Stem Cell Research Center at University Of Massachusetts March 7th, 2007 The University of Massachusetts could position itself as a contender in the stem cell research arena by developing a new system-wide institute to advance life sciences through human and animal research, according to a report to the university's board of trustees. UMass trustees plan to discuss the proposal when they meet March 14th in Worcester.
Leukemic stem cell killer 'omacetaxine' help rises Chemgenex's shareMarch 28th, 2009 ChemGenex Pharmaceuticals announced on March 26th, 2009 through online publication in the journal Leukemia, about the ability of omacetaxine to kill leukemic stem cells in mouse models with drug-resistant chronic myelogenous leukemia (CML). The findings of this study provide new insights into the problem of minimal residual disease and may open the door to the development of a curative treatment strategy for some patients with CML.
U.S. Scientists Discovered Technique For Embryonic Stem Cell ReprogrammingSeptember 15th, 2007 University of California-San Francisco researchers have said that they have significantly improved the technique for genetically reprogramming mouse cells to their embryonic state. The UCSF team said their new finding should accelerate research aimed at improving the original strategy, as well as increasing its potential use for studying disease development and creating patient-specific stem-cell based therapies.
Massachusetts launched world's most comprehensive stem cell database September 12th, 2008 In a unique attempt of its kind, the Massachusetts Medical School, has launched the embryonic stem-cell lines. It is claimed to be the most comprehensive embryonic stem database of the world.
Paraplegic to Sue Couple for Formulating Untested Stem Cell TherapyNovember 20th, 2006 Justine Asher, 35, a paraplegic who was told she could undergo a miracle cure called stem cell therapy for R120 000 to be able to walk again, has been given the go-ahead to sue the Cape Town businessman and his American girlfriend who formulated the "unsafe" and "untested" treatment. The couple, Stephen van Rooyen and Laura Brown are on the FBI's wanted list in the US and face a 51-count indictment handed down by a federal grand jury in Atlanta in March.
Way to go Massachusetts! Another state becomes wiser to the needs of stem cell researchApril 3rd, 2005 A bill that would allow embryonic stem cell research in Massachusetts cleared its second big legislative hurdle on Thursday with enough support to withstand a near-certain veto by the state's governor. Following impassioned argument on both sides, the state House of Representatives voted 117-37 in favor of legislation that endorses stem cell research, including stem cells obtained from cloned human embryos.
Massachusetts researchers claimed to have created pluripotent stem cells without side effect September 26th, 2008 Massachusetts researchers have found that the they have developed a method for generating induced pluripotent stem cells (iPS cells) without the side effects. The new study shows that that iPS cells can be grown using viruses that do not integrate themselves into the hosts' genome, bypassing a problem that has undermined the success of previous iPS cells.
Stem Cell Study Continues In Massachusetts, Despite Poltical And Religious Pressure: A ReportJuly 1st, 2008 Massachusetts, one of the richest states in the USA, is respected in the country as a state of liberal outlook. The town Cambridge is blessed with a number of the most advanced institutions and biotech companies in the world.
Leave a Comment
